Pre-made Zanidatamab Zovodotin benchmark antibody (Bispecific/biparatopic, anti-ERBB2/HER2;ERBB2/HER2 therapeutic antibody, Anti-CD340/MLN 19/NEU/NGL/TKR1/VSCN2;CD340/neu/MLN 19/NEU/NGL/TKR1/VSCN2 Antibody) for drug discovery and mechanism of action (MOA) research

Cat:GMP-Bios-INN-1055

* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

SKU GMP-Bios-INN-1055 Category Tag

Product Details

Pre-made Zanidatamab Zovodotin benchmark antibody (Bispecific/biparatopic, anti-ERBB2/HER2;ERBB2/HER2 therapeutic antibody, Anti-CD340/MLN 19/NEU/NGL/TKR1/VSCN2;CD340/neu/MLN 19/NEU/NGL/TKR1/VSCN2 Antibody) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Products Name (INN Index)

Pre-Made Zanidatamab Zovodotin B Zovodotiniosimilar, Bispecific/Biparatopic, Anti-ERBB2/HER2;ERBB2/HER2 Therapeutic/Biparatopic Antibody Antibody: Anti-CD340/MLN 19/NEU/NGL/TKR1/VSCN2;CD340/neu/MLN 1

INN Name

zanidatamab zovodotin

Target

ERBB2

Format

Bispecific/biparatopic

Derivation

NA

Species Reactivity

NA

CH1 Isotype

NA

VD LC

NA

Highest_Clin_Trial (Jan '20)

NA

Est. Status

NA

100% SI Structure

NA

99% SI Structure

NA

95-98% SI Structure

NA

Year Proposed

NA

Companies

NA

Conditions Approved

NA

Conditions Active

NA

Conditions Discontinued

NA

Development Tech

NA

Previous Name

NA

Gm Offical Target Name

ERBB2,ERBB2

Package

, ,

Genemeidi Omicron Variant Products
test
Previous slide
Next slide